JN0620 重组人VSIG4

我公司致力于为客户提供高纯度、低成本的活性重组蛋白，包括重组人VSIG4在内的各类受体、细胞因子、生长因子、转录因子、激素、酶、毒性蛋白、病毒抗原等。...

特别提示：包括重组人VSIG4(含V-set和Ig结构域蛋白4)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人VSIG4(含V-set和Ig结构域蛋白4)
英文名称：Recombinant Human V-Set and Immunoglobulin Domain-Containing Protein 4
产品货号：JN0620
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Arg20-Pro283在C端含有His标签。

VSIG4质量控制：＞95%(还原性SDS-PAGE)

VSIG4制剂：冻干品

VSIG4保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

VSIG4复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于VSIG4：
V-Set and Immunoglobulin Domain-Containing Protein 4 (VSIG4) is a 45-50 kDa macrophage-specific transmembrane glycoprotein that belongs to the B7 family-related protein and an Ig superfamily member. In contrast to the B7 family members which contain two IgG domains, VSIG4 contains one complete V-type Ig domain and a truncated C-type Ig domain. VSIG4 is abundantly expressed in several fetal tissues. In adult tissues, the highest expression of VSIG4 is in lung and placenta. It is also expressed in resting macrophages. No VSIG4 expression appears to be present in T and B cells. The specific expression of VSIG4 on resting macrophages in tissue suggests that this inhibitory ligand may be important for the maintenance of T cell unresponsiveness in healthy tissues. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. VSIG4 is a phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production. It is a potent inhibitor of the alternative complement pathway convertases. Human VSIG4 is 399 amino acids (aa) in length. It is a type I transmembrane (TM) glycoprotein that contains a 264 aa extracellular domain (ECD) (aa 20 - 283) and a 95 aa cytoplasmic region.

根据您的关注的重组人VSIG4(含V-set和Ig结构域蛋白4)，重组VSIG4，rVSIG4，重组人含V-set和Ig结构域蛋白4，rhVSIG4，重组人VSIG4(含V-set和Ig结构域蛋白4)，重组人V-Set and Immunoglobulin Domain-Containing Protein 4，含V-set和Ig结构域蛋白4，重组含V-set和Ig结构域蛋白4，重组人VSIG4，重组V-Set and Immunoglobulin Domain-Containing Protein 4，Recombinant Human V-Set and Immunoglobulin Domain-Containing Protein 4，JN0620，百奥莱博，，，您可能还对以下产品有需求：



名称：重组长尾猕猴成纤维生长因子21
货号：JN0285
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物表达系统制备，目的基因编码的His29-Ser209在C端含有His标签。

FGF-21质量控制：＞95%(还原性SDS-PAGE)。

FGF-21制剂：冻干品

FGF-21保存：
冻干蛋白可在-20℃长期保存，室温也可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天。
复溶后建议分装冻存在-20℃，可保存3个月，应避免反复冻融。

FGF-21复溶：
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存，避免反复冻融。

关于FGF-21：
Fibroblast Growth Factor 21 (FGF21) is a growth factor that belongs to the FGF family. FGF family proteins play a central role during prenatal development and postnatal growth and regeneration of mamy tissues, by promoting cellular proliferation and differentiation. FGF21 is a potent activator of glucose uptake on adipocytes, protects animal from diet-induced obesity when overexpression in transgenic mice, and lower blood glucose and triglyceride levels when therapeutically adiministered to diabetic redents. FGF21 is produced by hepatocytes in reponse to free fatty acid stimulation of a PPARa/RXR dimeric complex. This situation occurs clinically during starvation, or following the ingestionof a highly-fat/low-carbohydrate diet. Upon FGF21 secretion, white adipose tissue is induced to release free fatty acids from triglyceride stores. once free fatty acid reach hepatocytes, they are oxidized and reduced to acetyl-CoA. The acetyl-CoA is recombined into 4-carbon ketone bodies, release, and transported to peripheral tissue for TCA processing and energy generation.

关注重组人VSIG4(含V-set和Ig结构域蛋白4)，重组VSIG4，rVSIG4，重组人含V-set和Ig结构域蛋白4，rhVSIG4，重组人VSIG4(含V-set和Ig结构域蛋白4)，重组人V-Set and Immunoglobulin Domain-Containing Protein 4，含V-set和Ig结构域蛋白4，重组含V-set和Ig结构域蛋白4，重组人VSIG4，重组V-Set and Immunoglobulin Domain-Containing Protein 4，Recombinant Human V-Set and Immunoglobulin Domain-Containing Protein 4，JN0620，百奥莱博，，的同时，为您推荐更多您可能感兴趣的产品：


JN0427 重组人干扰素α1(IFN-α1) 10μg|50μg|500μg|1mg
JN0509 重组小鼠RANK(TNFRSF11A)(CD265) 10μg|50μg|500μg|1mg
JN1992 重组人细胞质动力蛋白轻链1(DYNLL1) 10μg|50μg|500μg|1mg
JN1997 重组人生长停滞特异性蛋白7(GAS-7) 10μg|50μg|500μg|1mg
JN2002 重组人LSM4蛋白 10μg|50μg|500μg|1mg
JN0822 重组人胰脂肪酶相关蛋白2(PNLIPRP2) 10μg|50μg|500μg|1mg
JN0839 重组人透明质酸酶1(Hyaluronidase-1) 10μg|50μg|500μg|1mg

如果您觉得“JN0620 重组人VSIG4”描述资料不够齐全，请联系我们获取详细资料。(联系时请告诉我从仪器交易网看到的，我们将给您最大优惠！)
本页链接：http://www.yi7.com/com_bjbiolab01/sell/itemid-8517323.html
已经有833位访客查看了本页.